MedTrace Logo

Effect of Bioptron Light Therapy on Dryness of Eyes in Postmenopausal Women

NCT05964673 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-08-30

No results posted yet for this study

Summary

Dry eye disease (DED) is a growing public health concern affecting quality of life and visual function, with a significant socio-economic impact. It is more prevalent in the females and is being specifically in the menopausal and postmenopausal age group.

Bioptron light therapy is efficient in the elimination of allergic reactions, signs and symptoms of dry eye improving capillary circulation, immunity stimulation, relieving pain and establishing balance of tissue electromagnetic field

Conditions

  • Postmenopausal Women

Interventions

DEVICE

bioptron light therapy

patients will receive patient education program and bioptron light therapy for four weeks

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Sara Ahmed, lecturer · giza, Egypt, 12511

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-09
Primary Completion
2023-09-19
Completion
2023-11-08
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05964673 on ClinicalTrials.gov